| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA topoisomerase type I (single strand cut, ATP-independent) activity | 2.12e-06 | 4 | 163 | 3 | GO:0003917 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HAUS6 DPYSL3 ANK2 ANK3 MAP1A GAPDH SYNM MYH7B SPTAN1 ANXA8L1 EML6 CKAP5 ANXA8 CLSTN1 USH1C KPTN DST PLEKHG3 ANKRD2 VPS41 KIF3C RP1 MYO18B EPB41L2 CAP1 | 3.16e-06 | 1099 | 163 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | spectrin binding | 7.83e-06 | 34 | 163 | 5 | GO:0030507 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MRE11 DNAH3 LONP2 MYH7B DDX60 DNAH2 SAE1 ABCC11 RNF213 ABCC9 CCT2 RFC3 ABCB11 KIF3C SNRNP200 DYNC1H1 DNAH11 | 1.17e-05 | 614 | 163 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.20e-05 | 18 | 163 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 LONP2 DDX60 DNAH2 ABCC11 RNF213 ABCC9 CCT2 RFC3 ABCB11 KIF3C SNRNP200 DYNC1H1 DNAH11 | 1.62e-05 | 441 | 163 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 2.90e-05 | 8 | 163 | 3 | GO:0003916 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.24e-05 | 118 | 163 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MTG1 DNAH3 HBS1L LONP2 DDX60 DNAH2 ABCC11 RNF213 ABCC9 CCT2 RFC3 ARL4A ABCB11 KIF3C GFM1 SNRNP200 DYNC1H1 DNAH11 | 6.55e-05 | 775 | 163 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.52e-05 | 28 | 163 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MTG1 DNAH3 HBS1L LONP2 DDX60 DNAH2 ABCC11 RNF213 ABCC9 CCT2 RFC3 ARL4A ABCB11 KIF3C GFM1 SNRNP200 DYNC1H1 DNAH11 | 1.77e-04 | 839 | 163 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MTG1 DNAH3 HBS1L LONP2 DDX60 DNAH2 ABCC11 RNF213 ABCC9 CCT2 RFC3 ARL4A ABCB11 KIF3C GFM1 SNRNP200 DYNC1H1 DNAH11 | 1.79e-04 | 840 | 163 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MTG1 DNAH3 HBS1L LONP2 DDX60 DNAH2 ABCC11 RNF213 ABCC9 CCT2 RFC3 ARL4A ABCB11 KIF3C GFM1 SNRNP200 DYNC1H1 DNAH11 | 1.79e-04 | 840 | 163 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 1.98e-04 | 3 | 163 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 1.98e-04 | 3 | 163 | 2 | GO:0019118 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.29e-04 | 37 | 163 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.69e-04 | 70 | 163 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 9.53e-04 | 24 | 163 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 9.72e-04 | 6 | 163 | 2 | GO:0004157 | |
| GeneOntologyMolecularFunction | microtubule binding | 9.90e-04 | 308 | 163 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.35e-03 | 27 | 163 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | actin binding | MAP1A MYH7B SPTAN1 ANXA8L1 ANXA8 KPTN DST PLEKHG3 MYO18B EPB41L2 CAP1 | 1.97e-03 | 479 | 163 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 2.23e-03 | 32 | 163 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.30e-03 | 9 | 163 | 2 | GO:0034040 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNAH3 ANK3 MAP1A DNAH2 ODAD2 AP3B1 QRICH2 PGK2 FSIP2 CFAP54 DST KIF3C CFAP69 DYNC1H1 DNAH11 | 7.77e-06 | 493 | 161 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | cilium movement | DNAH3 DNAH2 ODAD2 QRICH2 PGK2 FSIP2 CFAP54 CFAP69 DYNC1H1 DNAH11 | 4.03e-05 | 261 | 161 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis | MAP1A GAPDH COL28A1 KLHL40 ANXA8L1 ANXA8 QRICH2 A2ML1 PAK2 PRKCG ANKS1A | 5.27e-05 | 326 | 161 | 11 | GO:0045861 |
| GeneOntologyBiologicalProcess | DNA topological change | 5.38e-05 | 10 | 161 | 3 | GO:0006265 | |
| GeneOntologyBiologicalProcess | microtubule-based process | DNAH3 HAUS6 ANK3 MAP1A GAPDH KIZ DNAH2 CKAP5 ODAD2 AP3B1 QRICH2 PGK2 FSIP2 CFAP54 DST TNKS KIF3C RP1 CFAP69 DYNC1H1 DNAH11 | 7.88e-05 | 1058 | 161 | 21 | GO:0007017 |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH3 DPYSL2 HAUS6 DPYSL3 ANK2 ANK3 MAP1A SYNM MYH7B COL28A1 KLHL40 PPP1R12B SPTAN1 EML6 DNAH2 CKAP5 ABCC9 CCT2 KLHL22 KPTN DST SYNJ1 ANKRD2 KIF3C RP1 MYO18B DYNC1H1 DNAH11 | 8.23e-08 | 1179 | 160 | 28 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH3 DPYSL2 HAUS6 DPYSL3 ANK2 ANK3 MAP1A SYNM MYH7B COL28A1 KLHL40 PPP1R12B SPTAN1 EML6 DNAH2 CKAP5 ABCC9 CCT2 KLHL22 KPTN DST SYNJ1 ANKRD2 KIF3C RP1 MYO18B DYNC1H1 DNAH11 | 9.47e-08 | 1187 | 160 | 28 | GO:0099081 |
| GeneOntologyCellularComponent | cytoplasmic region | DNAH3 MAP1A ERC1 DNAH2 CKAP5 ODAD2 AP3B1 CFAP54 DST KIF3C RP1 CFAP69 DYNC1H1 DNAH11 | 7.47e-07 | 360 | 160 | 14 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DNAH3 MAP1A DNAH2 CKAP5 ODAD2 AP3B1 CFAP54 DST KIF3C RP1 CFAP69 DYNC1H1 DNAH11 | 1.05e-06 | 317 | 160 | 13 | GO:0032838 |
| GeneOntologyCellularComponent | I band | 5.47e-06 | 166 | 160 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | ANK2 ANK3 SYNM MYH7B KLHL40 PPP1R12B SPTAN1 ABCC9 DST ANKRD2 MYO18B | 8.58e-06 | 273 | 160 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | ANK2 ANK3 SYNM MYH7B KLHL40 PPP1R12B SPTAN1 ABCC9 DST ANKRD2 MYO18B | 1.51e-05 | 290 | 160 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | microtubule | DNAH3 DPYSL2 HAUS6 MAP1A EML6 DNAH2 CKAP5 CCT2 KLHL22 DST SYNJ1 KIF3C RP1 DYNC1H1 DNAH11 | 1.55e-05 | 533 | 160 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | sarcomere | ANK2 ANK3 SYNM KLHL40 PPP1R12B SPTAN1 ABCC9 DST ANKRD2 MYO18B | 2.29e-05 | 249 | 160 | 10 | GO:0030017 |
| GeneOntologyCellularComponent | microtubule associated complex | 3.45e-05 | 161 | 160 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | postsynaptic density | DPYSL2 ANK2 ANK3 MAP1A GAPDH ERC1 MPDZ CLSTN1 BNIP3 DST PAK2 PRKCG EPHA7 | 4.57e-05 | 451 | 160 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DNAH3 DPYSL2 HAUS6 DPYSL3 MAP1A SYNM EML6 DNAH2 CKAP5 CCT2 KLHL22 KPTN DST SYNJ1 KIF3C RP1 MYO18B DYNC1H1 DNAH11 | 6.03e-05 | 899 | 160 | 19 | GO:0099513 |
| GeneOntologyCellularComponent | asymmetric synapse | DPYSL2 ANK2 ANK3 MAP1A GAPDH ERC1 MPDZ CLSTN1 BNIP3 DST PAK2 PRKCG EPHA7 | 8.07e-05 | 477 | 160 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | DPYSL2 ANK2 ANK3 MAP1A GAPDH ERC1 MPDZ CLSTN1 BNIP3 DST PAK2 PRKCG EPHA7 | 1.37e-04 | 503 | 160 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | Z disc | 1.66e-04 | 151 | 160 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | DPYSL2 ANK2 ANK3 MAP1A GAPDH ERC1 MPDZ CLSTN1 BNIP3 DST PAK2 PRKCG EPHA7 | 2.00e-04 | 523 | 160 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 2.03e-04 | 110 | 160 | 6 | GO:0120111 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.08e-04 | 238 | 160 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | cilium | DNAH3 MAP1A TCP11X2 ERC1 DNAH2 ARMC9 ODAD2 USH1C QRICH2 PGK2 BBS10 FSIP2 CFAP54 KIF3C RP1 CFAP69 DNAH11 | 5.38e-04 | 898 | 160 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | costamere | 6.09e-04 | 22 | 160 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cell-cell junction | JCAD ANK2 ANK3 SYNM SPTAN1 MPDZ TGM1 CDH24 DST PAK2 ABCB11 PRKCG MMP13 | 6.40e-04 | 591 | 160 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | sarcolemma | 6.65e-04 | 190 | 160 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | A band | 6.72e-04 | 52 | 160 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | dynein complex | 7.76e-04 | 54 | 160 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | postsynapse | DPYSL2 ANK2 ANK3 MAP1A GAPDH ERC1 SPTAN1 MPDZ NBEA CLSTN1 KPTN BNIP3 DST PAK2 PRKCG PCDH8 CAP1 EPHA7 | 8.16e-04 | 1018 | 160 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | axoneme | 1.10e-03 | 207 | 160 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.13e-03 | 208 | 160 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.25e-03 | 28 | 160 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | IkappaB kinase complex | 1.58e-03 | 8 | 160 | 2 | GO:0008385 | |
| GeneOntologyCellularComponent | external encapsulating structure | IL16 MXRA5 COL28A1 ANXA8 MUC5B ZP2 PKHD1L1 THBS2 DST LRRN2 MMP12 MMP13 PLOD1 | 1.69e-03 | 658 | 160 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | axon cytoplasm | 1.84e-03 | 68 | 160 | 4 | GO:1904115 | |
| GeneOntologyCellularComponent | intercalated disc | 1.84e-03 | 68 | 160 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 2.02e-03 | 9 | 160 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | spectrin | 2.02e-03 | 9 | 160 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.52e-03 | 10 | 160 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | neuronal ribonucleoprotein granule | 2.52e-03 | 10 | 160 | 2 | GO:0071598 | |
| GeneOntologyCellularComponent | filamentous actin | 3.05e-03 | 38 | 160 | 3 | GO:0031941 | |
| GeneOntologyCellularComponent | microtubule end | 3.05e-03 | 38 | 160 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | paranodal junction | 3.06e-03 | 11 | 160 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 3.29e-03 | 39 | 160 | 3 | GO:0031463 | |
| GeneOntologyCellularComponent | anchoring junction | JCAD IL16 ANK2 ANK3 SYNM SPTAN1 MPDZ TGM1 CDH24 DST PAK2 ABCB11 PRKCG MMP13 EPB41L2 CAP1 | 3.40e-03 | 976 | 160 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | AP-3 adaptor complex | 4.30e-03 | 13 | 160 | 2 | GO:0030123 | |
| GeneOntologyCellularComponent | extracellular matrix | IL16 MXRA5 COL28A1 ANXA8 MUC5B ZP2 THBS2 DST LRRN2 MMP12 MMP13 PLOD1 | 4.69e-03 | 656 | 160 | 12 | GO:0031012 |
| Domain | AAA | DNAH3 LONP2 DNAH2 ABCC11 RNF213 ABCC9 RFC3 ABCB11 SNRNP200 DYNC1H1 DNAH11 | 4.83e-08 | 144 | 161 | 11 | SM00382 |
| Domain | AAA+_ATPase | DNAH3 LONP2 DNAH2 ABCC11 RNF213 ABCC9 RFC3 ABCB11 SNRNP200 DYNC1H1 DNAH11 | 4.83e-08 | 144 | 161 | 11 | IPR003593 |
| Domain | P-loop_NTPase | MTG1 DNAH3 HBS1L LONP2 MYH7B DDX60 DNAH2 ABCC11 RNF213 ABCC9 GIMAP1 RFC3 ARL4A NLRP14 NLRC5 ABCB11 KIF3C MYO18B GFM1 SNRNP200 DYNC1H1 DNAH11 | 3.85e-06 | 848 | 161 | 22 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 4.98e-06 | 14 | 161 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.98e-06 | 14 | 161 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.98e-06 | 14 | 161 | 4 | IPR013602 | |
| Domain | DHC_N2 | 4.98e-06 | 14 | 161 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.98e-06 | 14 | 161 | 4 | IPR011704 | |
| Domain | MT | 4.98e-06 | 14 | 161 | 4 | PF12777 | |
| Domain | AAA_8 | 4.98e-06 | 14 | 161 | 4 | PF12780 | |
| Domain | AAA_5 | 4.98e-06 | 14 | 161 | 4 | PF07728 | |
| Domain | DHC_fam | 6.74e-06 | 15 | 161 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 6.74e-06 | 15 | 161 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.74e-06 | 15 | 161 | 4 | IPR004273 | |
| Domain | - | MTG1 DNAH3 HBS1L LONP2 DDX60 DNAH2 ABCC11 RNF213 ABCC9 GIMAP1 RFC3 ARL4A NLRP14 NLRC5 ABCB11 GFM1 SNRNP200 DYNC1H1 DNAH11 | 2.40e-05 | 746 | 161 | 19 | 3.40.50.300 |
| Domain | DHC_N1 | 3.41e-05 | 8 | 161 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.41e-05 | 8 | 161 | 3 | IPR013594 | |
| Domain | Topo_IA_2 | 7.39e-05 | 2 | 161 | 2 | IPR003601 | |
| Domain | Topo_IA_DNA-bd_dom | 7.39e-05 | 2 | 161 | 2 | IPR003602 | |
| Domain | - | 7.39e-05 | 2 | 161 | 2 | 2.70.20.10 | |
| Domain | AnnexinVIII | 7.39e-05 | 2 | 161 | 2 | IPR009115 | |
| Domain | Topo_IA_core_domain | 7.39e-05 | 2 | 161 | 2 | IPR023405 | |
| Domain | Topo_IA_AS | 7.39e-05 | 2 | 161 | 2 | IPR023406 | |
| Domain | Topo_IA_cen_sub1 | 7.39e-05 | 2 | 161 | 2 | IPR013824 | |
| Domain | Topo_IA_cen | 7.39e-05 | 2 | 161 | 2 | IPR013497 | |
| Domain | - | 7.39e-05 | 2 | 161 | 2 | 3.40.50.140 | |
| Domain | Topo_IA | 7.39e-05 | 2 | 161 | 2 | IPR000380 | |
| Domain | TOP1Bc | 7.39e-05 | 2 | 161 | 2 | SM00436 | |
| Domain | TOP1Ac | 7.39e-05 | 2 | 161 | 2 | SM00437 | |
| Domain | - | 7.39e-05 | 2 | 161 | 2 | 1.10.460.10 | |
| Domain | Topoisom_bac | 7.39e-05 | 2 | 161 | 2 | PF01131 | |
| Domain | TOPOISOMERASE_I_PROK | 7.39e-05 | 2 | 161 | 2 | PS00396 | |
| Domain | TOPRIM | 7.39e-05 | 2 | 161 | 2 | SM00493 | |
| Domain | Ank | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 1.65e-04 | 228 | 161 | 9 | PF00023 |
| Domain | Topo_IA_cen_sub2 | 2.20e-04 | 3 | 161 | 2 | IPR013825 | |
| Domain | ANK | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 3.36e-04 | 251 | 161 | 9 | SM00248 |
| Domain | ANK_REPEAT | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 3.56e-04 | 253 | 161 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 3.66e-04 | 254 | 161 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 3.66e-04 | 254 | 161 | 9 | PS50297 |
| Domain | Toprim | 4.38e-04 | 4 | 161 | 2 | PF01751 | |
| Domain | Toprim_domain | 4.38e-04 | 4 | 161 | 2 | IPR006171 | |
| Domain | TOPRIM | 4.38e-04 | 4 | 161 | 2 | PS50880 | |
| Domain | Ankyrin_rpt | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 4.59e-04 | 262 | 161 | 9 | IPR002110 |
| Domain | SAM/pointed | 5.32e-04 | 117 | 161 | 6 | IPR013761 | |
| Domain | Ank_2 | 5.64e-04 | 215 | 161 | 8 | PF12796 | |
| Domain | Hydantoinase/dihydroPyrase | 1.08e-03 | 6 | 161 | 2 | IPR011778 | |
| Domain | ABC_membrane | 1.11e-03 | 24 | 161 | 3 | PF00664 | |
| Domain | Metal_Hydrolase | 1.11e-03 | 24 | 161 | 3 | IPR032466 | |
| Domain | - | 1.42e-03 | 248 | 161 | 8 | 1.25.40.20 | |
| Domain | HEAT | 1.57e-03 | 58 | 161 | 4 | IPR000357 | |
| Domain | DEATH | 1.58e-03 | 27 | 161 | 3 | SM00005 | |
| Domain | ABC_TM1F | 1.76e-03 | 28 | 161 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.76e-03 | 28 | 161 | 3 | IPR011527 | |
| Domain | - | 2.00e-03 | 8 | 161 | 2 | 2.30.40.10 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MRE11 HBS1L DPYSL2 GAPDH SPTAN1 POLR2B CGAS CKAP5 ACOT7 SAE1 CCT2 RFC3 ANKHD1 ELAC2 TGM1 ADPRS SF3B1 DST PLEKHG3 A2ML1 AHCY CSTF1 UQCRC1 IK PLOD1 SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 | 1.50e-12 | 1353 | 164 | 30 | 29467282 |
| Pubmed | MRE11 HBS1L HAUS6 ANK2 ANK3 GAPDH ERC1 CKAP5 MPDZ CCT2 AP3B1 KIDINS220 DST AHCY PAK2 CRYBG3 SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 ANKS1A | 3.25e-12 | 708 | 164 | 22 | 39231216 | |
| Pubmed | MRE11 HBS1L DPYSL2 HAUS6 DPYSL3 ANK3 GAPDH ERC1 SPTAN1 POLR2B MPDZ CCT2 AP3B1 ANKHD1 SYNJ1 PAK2 IK SNRNP200 DYNC1H1 | 1.74e-11 | 549 | 164 | 19 | 38280479 | |
| Pubmed | CDK17 DPYSL2 DPYSL3 IL16 ANK2 ANK3 MAP1A GAPDH ERC1 PPP1R12B SPTAN1 CKAP5 ACOT7 NBEA CCT2 AP3B1 TGM1 KIDINS220 SF3B1 DST SYNJ1 PRKCG UQCRC1 SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 DNAH11 | 3.22e-11 | 1431 | 164 | 29 | 37142655 | |
| Pubmed | JCAD DPYSL2 ANK2 ANK3 SYNM ERC1 SPTAN1 ZBTB43 CKAP5 SESN3 NBEA CCT2 ARMCX4 SARS2 SF3B1 DST SYNJ1 AHCY PAK2 LRRN2 TNKS UQCRC1 SNRNP200 TOP1 DYNC1H1 | 1.98e-09 | 1285 | 164 | 25 | 35914814 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MRE11 DPYSL2 HAUS6 DPYSL3 ANK2 MAP1A GAPDH ERC1 CKAP5 ACOT7 CCT2 ANKHD1 SF3B1 DST SYNJ1 AHCY PAK2 SNRNP200 TOP1 EPB41L2 ANKS1A | 3.66e-09 | 934 | 164 | 21 | 33916271 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MRE11 HBS1L DPYSL2 DPYSL3 PDE3A GAPDH SPTAN1 POLR2B ACOT7 SAE1 CCT2 ARMC9 RFC3 PPAT AP3B1 ELAC2 AHCY PAK2 IKBKB PLOD1 SNRNP200 DYNC1H1 SEC23B EPB41L2 CAP1 ANKS1A | 5.28e-09 | 1455 | 164 | 26 | 22863883 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MRE11 DPYSL2 DPYSL3 ANK3 GAPDH ERC1 SPTAN1 POLR2B CKAP5 ACOT7 SAE1 MPDZ CCT2 AP3B1 ANKHD1 SF3B1 DST AHCY SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 | 5.54e-09 | 1149 | 164 | 23 | 35446349 |
| Pubmed | DPYSL2 ANK2 ANK3 ERC1 SPTAN1 CKAP5 MPDZ NBEA ARMCX4 SF3B1 DST SYNJ1 DZIP3 PAK2 PRKCG TNKS TOP3B PCDH8 DYNC1H1 EPB41L2 ANKS1A | 6.23e-09 | 963 | 164 | 21 | 28671696 | |
| Pubmed | HBS1L DPYSL2 PDE3A GAPDH SPTAN1 POLR2B CCT2 ANKHD1 GOSR2 ELAC2 KIDINS220 SF3B1 DST AHCY CSTF1 UQCRC1 IKBKB PLOD1 TOP3B TOP1 PIGO DYNC1H1 SEC23B EPB41L2 | 1.13e-08 | 1297 | 164 | 24 | 33545068 | |
| Pubmed | MRE11 DPYSL2 SPTAN1 CKAP5 CCT2 ANKHD1 SF3B1 DST UQCRC1 IK PLOD1 SNRNP200 TOP1 DYNC1H1 SEC23B EPB41L2 CAP1 | 1.51e-08 | 653 | 164 | 17 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRE11 HBS1L GAPDH SPTAN1 POLR2B CKAP5 CCT2 RFC3 PPAT AP3B1 ANKHD1 KIDINS220 SF3B1 AHCY CSTF1 KIF3C UQCRC1 MYO18B IK GFM1 SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 | 1.55e-08 | 1425 | 164 | 25 | 30948266 |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | DPYSL2 GAPDH CKAP5 CCT2 RFC3 KLHL22 KLHL13 AHCY PLOD1 DYNC1H1 | 1.76e-08 | 182 | 164 | 10 | 31067453 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MRE11 DNAH3 DPYSL2 DPYSL3 ERC1 SPTAN1 DNAH2 CKAP5 SAE1 CCT2 PPAT AP3B1 ELAC2 PGK2 SF3B1 SNRNP200 TOP1 DYNC1H1 EPB41L2 | 2.22e-08 | 847 | 164 | 19 | 35235311 |
| Pubmed | JCAD DPYSL2 ANK2 ANK3 MAP1A GAPDH ERC1 SPTAN1 ANXA8L1 CKAP5 NBEA ANXA8 SF3B1 SYNJ1 AKR7L AKR7A3 PRKCG CRYBG3 GFM1 PCDH8 EPB41L2 CAP1 | 2.31e-08 | 1139 | 164 | 22 | 36417873 | |
| Pubmed | HAUS6 ANK3 GAPDH SYNM RNF213 NBEA PODXL2 CCT2 RFC3 AP3B1 PKHD1L1 KIDINS220 SF3B1 DST SNRNP200 DYNC1H1 SEC23B EPB41L2 | 3.30e-08 | 777 | 164 | 18 | 35844135 | |
| Pubmed | DPYSL2 ANK2 ANK3 SPTAN1 MPDZ NBEA SYNJ1 PRKCG DYNC1H1 EPB41L2 ANKS1A | 3.45e-08 | 251 | 164 | 11 | 27507650 | |
| Pubmed | 4.60e-08 | 151 | 164 | 9 | 17043677 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | DPYSL2 DPYSL3 MAP1A GAPDH ERC1 SPTAN1 ABCC9 CCT2 DST SYNJ1 EFHD1 AHCY PRKCG UQCRC1 DYNC1H1 EPB41L2 | 4.73e-08 | 621 | 164 | 16 | 22794259 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MRE11 HBS1L GAPDH LONP2 ERC1 SPTAN1 POLR2B CKAP5 CCT2 FNBP1L RFC3 AP3B1 ANKHD1 PTER ELAC2 SF3B1 AHCY IK PLOD1 SNRNP200 TOP1 DYNC1H1 SEC23B EPB41L2 | 5.83e-08 | 1415 | 164 | 24 | 28515276 |
| Pubmed | DPYSL2 DPYSL3 MAP1A POLR2B RNF213 CCT2 ANKHD1 CRYBG3 SNRNP200 | 6.10e-08 | 156 | 164 | 9 | 32850835 | |
| Pubmed | DPYSL2 DPYSL3 ANK2 ANK3 MAP1A GAPDH SPTAN1 CCT2 SYNJ1 PRKCG UQCRC1 DYNC1H1 CAP1 | 7.07e-08 | 403 | 164 | 13 | 30562941 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | GAPDH SPTAN1 POLR2B CKAP5 CCT2 RFC3 SF3B1 SNRNP200 TOP1 DYNC1H1 | 1.09e-07 | 221 | 164 | 10 | 29991511 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JCAD CDK17 DPYSL3 ERC1 SPTAN1 CKAP5 MPDZ PTER MAP3K6 FSIP2 DST SYNJ1 PLEKHG3 PRKCG CRYBG3 SEC23B EPB41L2 ANKS1A | 1.52e-07 | 861 | 164 | 18 | 36931259 |
| Pubmed | MRE11 HBS1L ANK2 CKAP5 NBEA CCT2 RFC3 ANKHD1 GOSR2 KIDINS220 SEC23B EPB41L2 ANKS1A | 2.44e-07 | 449 | 164 | 13 | 31732153 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MRE11 MAP1A POLR2B ACOT7 SAE1 RFC3 AP3B1 ANKHD1 AHCY UQCRC1 IK SNRNP200 TOP1 DYNC1H1 SEC23B EPB41L2 | 2.58e-07 | 704 | 164 | 16 | 29955894 |
| Pubmed | GAPDH SYNM SPTAN1 POLR2B SAE1 CCT2 ANKHD1 SF3B1 DST MYO18B SNRNP200 TOP1 DYNC1H1 CAP1 | 3.01e-07 | 538 | 164 | 14 | 28524877 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MRE11 DPYSL2 HAUS6 MAP1A ERC1 DDX60 SPTAN1 CKAP5 FNBP1L AP3B1 ANKHD1 PAK2 IK PLOD1 TOP3B TOP1 | 3.74e-07 | 724 | 164 | 16 | 36232890 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | MRE11 HAUS6 SYNM SPTAN1 CKAP5 KIDINS220 SF3B1 SNRNP200 DYNC1H1 EPB41L2 | 4.26e-07 | 256 | 164 | 10 | 33397691 |
| Pubmed | 4.60e-07 | 14 | 164 | 4 | 9373155 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MRE11 GAPDH SYNM ERC1 DDX60 SPTAN1 POLR2B CGAS CKAP5 CCT2 RFC3 LRCH1 SF3B1 DST PLEKHG3 AHCY IK SNRNP200 TOP1 DYNC1H1 EPB41L2 | 5.43e-07 | 1257 | 164 | 21 | 36526897 |
| Pubmed | DPYSL2 DPYSL3 ANK3 GAPDH RNF213 CCT2 PTER TGM1 SF3B1 DST AHCY UQCRC1 SNRNP200 TOP1 DYNC1H1 SEC23B CAP1 | 5.75e-07 | 844 | 164 | 17 | 25963833 | |
| Pubmed | MRE11 GAPDH SPTAN1 CCT2 LEPR EFHD1 GFM1 SNRNP200 TOP1 DYNC1H1 EPB41L2 | 6.05e-07 | 334 | 164 | 11 | 30425250 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTIF3 MTG1 SYNM POLR2B RNF213 CCT2 ARMCX4 PPAT GOSR2 ELAC2 BNIP3 SARS2 DST UQCRC1 CRYBG3 SLC30A9 GFM1 DHTKD1 PLOD1 TOP3B TOP1 SEC23B TOP3A | 6.31e-07 | 1496 | 164 | 23 | 32877691 |
| Pubmed | DPYSL2 DPYSL3 ANK2 MAP1A SPTAN1 NBEA FNBP1L BNIP3 DST SYNJ1 PRKCG | 8.79e-07 | 347 | 164 | 11 | 17114649 | |
| Pubmed | 9.22e-07 | 215 | 164 | 9 | 35973513 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DPYSL2 ANK2 ANK3 MAP1A SPTAN1 NBEA SYNJ1 PRKCG DYNC1H1 EPB41L2 | 9.93e-07 | 281 | 164 | 10 | 28706196 |
| Pubmed | 1.09e-06 | 284 | 164 | 10 | 29459677 | ||
| Pubmed | DPYSL2 HAUS6 MAP1A DHRS4L2 CKAP5 ACOT7 SAE1 ANKHD1 SF3B1 AHCY GFM1 DYNC1H1 EPB41L2 | 1.70e-06 | 534 | 164 | 13 | 35032548 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | DPYSL2 DPYSL3 GAPDH SPTAN1 POLR2B CLSTN1 SF3B1 SNRNP200 EPB41L2 | 1.92e-06 | 235 | 164 | 9 | 30258100 |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 2.04e-06 | 6 | 164 | 3 | 23728480 | |
| Pubmed | HBS1L ADAM21 PPP1R12B POLR2B DNAH2 TGM1 BNIP3 AHCY PAK2 PRKCG UQCRC1 MMP12 MMP13 SEC23B DNAH11 | 2.16e-06 | 730 | 164 | 15 | 34857952 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MRE11 DNAH3 DPYSL2 MXRA5 GAPDH COL28A1 DNAH2 CKAP5 RNF213 NBEA QRICH2 DST SNRNP200 DYNC1H1 EPB41L2 | 2.38e-06 | 736 | 164 | 15 | 29676528 |
| Pubmed | DPYSL2 DPYSL3 GAPDH SPTAN1 ACOT7 SAE1 CCT2 SYNJ1 AHCY UQCRC1 DYNC1H1 EPB41L2 CAP1 | 2.44e-06 | 552 | 164 | 13 | 36293380 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | DPYSL2 DPYSL3 ANK2 ANK3 MAP1A ERC1 SPTAN1 CCT2 FSIP2 AHCY UQCRC1 DYNC1H1 CAP1 | 2.74e-06 | 558 | 164 | 13 | 35063084 |
| Pubmed | 3.54e-06 | 49 | 164 | 5 | 20471030 | ||
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 9256245 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 3.55e-06 | 7 | 164 | 3 | 7495297 | |
| Pubmed | HBS1L HAUS6 SYNM RNF213 CLSTN1 TBC1D9 TULP4 PLEKHG3 DHTKD1 SNRNP200 RIC1 PDZRN4 | 4.31e-06 | 493 | 164 | 12 | 15368895 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MRE11 GAPDH SPTAN1 CKAP5 CCT2 RFC3 AP3B1 SF3B1 IK SNRNP200 TOP1 DYNC1H1 SEC23B | 4.33e-06 | 582 | 164 | 13 | 20467437 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | MRE11 SPTAN1 CKAP5 SAE1 RNF213 CCT2 ELAC2 SF3B1 SNRNP200 DYNC1H1 | 4.40e-06 | 332 | 164 | 10 | 32786267 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | GAPDH SPTAN1 CKAP5 SAE1 RNF213 CCT2 KLHL22 KLHL13 AHCY KIF3C SNRNP200 CAP1 | 4.49e-06 | 495 | 164 | 12 | 28581483 |
| Pubmed | DPYSL3 GAPDH SPTAN1 CCT2 SF3B1 DST SYNJ1 CSTF1 IK SNRNP200 DYNC1H1 CAP1 | 5.61e-06 | 506 | 164 | 12 | 30890647 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ANK3 GAPDH ERC1 SPTAN1 ACOT7 CCT2 MUC5B AP3B1 DST AHCY UQCRC1 SNRNP200 TOP1 DYNC1H1 CAP1 | 7.20e-06 | 807 | 164 | 15 | 30575818 |
| Pubmed | 7.28e-06 | 209 | 164 | 8 | 36779422 | ||
| Pubmed | GAPDH NT5E BSPRY PPP1R12B SPTAN1 POLR2B ACOT7 SAE1 CCT2 RFC3 AP3B1 ELAC2 SF3B1 TULP4 AHCY IK TOP1 DYNC1H1 CAP1 | 7.36e-06 | 1247 | 164 | 19 | 27684187 | |
| Pubmed | 8.68e-06 | 283 | 164 | 9 | 21903422 | ||
| Pubmed | 1.06e-05 | 220 | 164 | 8 | 24550385 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CDK17 GAPDH ERC1 POLR2B SAE1 AP3B1 QRICH2 ELAC2 KPTN SARS2 SF3B1 EFHD1 AHCY PAK2 UQCRC1 SNRNP200 DYNC1H1 EPB41L2 ANKS1A | 1.11e-05 | 1284 | 164 | 19 | 17353931 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.21e-05 | 10 | 164 | 3 | 22159418 | |
| Pubmed | CKAP5 FNBP1L KIDINS220 SYNJ1 VPS41 C1R WDR45B KIF3C SEC23B ANKS1A | 1.36e-05 | 378 | 164 | 10 | 34315543 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | JCAD HBS1L DPYSL2 HAUS6 DPYSL3 ERC1 KIZ POLR2B CKAP5 CCT2 KLHL22 SYNJ1 PLOD1 DYNC1H1 ANKS1A | 1.38e-05 | 853 | 164 | 15 | 28718761 |
| Pubmed | 1.53e-05 | 304 | 164 | 9 | 32235678 | ||
| Pubmed | MTG1 HBS1L GAPDH DDX60 POLR2B AP3B1 SF3B1 AHCY PLOD1 SNRNP200 TOP1 | 1.54e-05 | 469 | 164 | 11 | 37314180 | |
| Pubmed | HBS1L DPYSL2 HAUS6 POLR2B CKAP5 AP3B1 UQCRC1 IK GFM1 SNRNP200 DYNC1H1 EPB41L2 | 1.54e-05 | 560 | 164 | 12 | 35241646 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MTIF3 DPYSL2 MAP1A SPTAN1 POLR2B PODXL2 LRCH1 KIDINS220 SF3B1 DST CSTF1 IK PLOD1 SNRNP200 TOP1 DYNC1H1 SEC23B | 1.55e-05 | 1082 | 164 | 17 | 38697112 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MRE11 DPYSL2 BSPRY CKAP5 ACOT7 SAE1 MPDZ RFC3 AP3B1 ANKHD1 KIDINS220 CSTF1 TNKS GFM1 PLOD1 SNRNP200 | 1.63e-05 | 974 | 164 | 16 | 28675297 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | MTG1 DPYSL2 GAPDH RNF213 CCT2 GOSR2 CLSTN1 THBS2 AKR7L AKR7A3 C1R KIF3C UQCRC1 GFM1 PLOD1 SNRNP200 TOP1 PIGO SEC23B EPB41L2 | 1.79e-05 | 1451 | 164 | 20 | 30550785 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | HBS1L GAPDH POLR2B MPDZ CCT2 RFC3 ANKHD1 EFHD1 A2ML1 UQCRC1 DYNC1H1 SEC23B | 1.87e-05 | 571 | 164 | 12 | 37167062 |
| Pubmed | CDK17 DPYSL2 DPYSL3 GAPDH MYH7B ACOT7 SAE1 CCT2 RFC3 PPAT SF3B1 AHCY UQCRC1 DYNC1H1 EPB41L2 | 1.93e-05 | 878 | 164 | 15 | 37223481 | |
| Pubmed | PDE3A GAPDH POLR2B CKAP5 RFC3 LRCH1 AHCY PAK2 DYNC1H1 EPB41L2 | 2.16e-05 | 399 | 164 | 10 | 37536630 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 1364010 | ||
| Pubmed | Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. | 2.21e-05 | 2 | 164 | 2 | 29306076 | |
| Pubmed | Bone matrix regulates osteoclast differentiation and annexin A8 gene expression. | 2.21e-05 | 2 | 164 | 2 | 21344395 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 38880789 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 16203777 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 30031810 | ||
| Pubmed | PKCÎł-Mediated Phosphorylation of CRMP2 Regulates Dendritic Outgrowth in Cerebellar Purkinje Cells. | 2.21e-05 | 2 | 164 | 2 | 32860158 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 11917092 | ||
| Pubmed | Elevated Thrombospondin 2 Contributes to Delayed Wound Healing in Diabetes. | 2.21e-05 | 2 | 164 | 2 | 31391172 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22826151 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 34756877 | ||
| Pubmed | Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. | 2.21e-05 | 2 | 164 | 2 | 17373717 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24769558 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 23898086 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 8750872 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20376807 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 26438797 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 15928709 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 2.21e-05 | 2 | 164 | 2 | 25383926 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 19258954 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 25803307 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 12689944 | ||
| Pubmed | GAPDH ERC1 SPTAN1 CKAP5 CCT2 KLHL22 SF3B1 AHCY SNRNP200 SEC23B CAP1 | 2.48e-05 | 494 | 164 | 11 | 26831064 | |
| Pubmed | CDK17 ANK2 ANK3 SYNM SPTAN1 POLR2B MPDZ AP3B1 GOSR2 ELAC2 SARS2 KIDINS220 SF3B1 CRYBG3 SLC30A9 PLOD1 TOP3B SNRNP200 EPB41L2 EPHA7 | 2.53e-05 | 1487 | 164 | 20 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DDR1 DPYSL2 ANK3 KIZ RNF213 FOXN3 FNBP1L ANKRD44 KIDINS220 TULP4 PLEKHG3 EFHD1 VPS41 NLRC5 WDR45B UQCRC1 PLOD1 CFAP69 RIC1 ANKS1A | 2.58e-05 | 1489 | 164 | 20 | 28611215 |
| Pubmed | 2.72e-05 | 327 | 164 | 9 | 31409639 | ||
| Pubmed | 2.92e-05 | 330 | 164 | 9 | 32529326 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GAPDH POLR2B SAE1 CCT2 RFC3 PPAT ELAC2 SARS2 SF3B1 KLHL13 AHCY CSTF1 IK GFM1 PLOD1 SNRNP200 DYNC1H1 SEC23B | 2.95e-05 | 1257 | 164 | 18 | 37317656 |
| Interaction | KCNA3 interactions | MRE11 HBS1L HAUS6 IL16 ANK2 ANK3 GAPDH MYH7B ERC1 CKAP5 MPDZ RNF213 CCT2 AP3B1 KIDINS220 DST AHCY PAK2 RP1 CRYBG3 SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 ANKS1A | 9.38e-09 | 871 | 164 | 26 | int:KCNA3 |
| Interaction | KCTD13 interactions | CDK17 DPYSL2 DPYSL3 IL16 ANK2 ANK3 MAP1A GAPDH ERC1 PPP1R12B SPTAN1 CKAP5 ACOT7 NBEA CCT2 AP3B1 TGM1 KIDINS220 SF3B1 DST SYNJ1 PRKCG UQCRC1 SNRNP200 TOP1 DYNC1H1 EPB41L2 CAP1 DNAH11 | 2.61e-06 | 1394 | 164 | 29 | int:KCTD13 |
| Interaction | D2HGDH interactions | 3.13e-06 | 146 | 164 | 9 | int:D2HGDH | |
| Interaction | AGAP2 interactions | DPYSL2 ANK2 ANK3 MAP1A SPTAN1 NBEA SYNJ1 PRKCG DYNC1H1 EPB41L2 | 8.86e-06 | 210 | 164 | 10 | int:AGAP2 |
| Interaction | HIF1AN interactions | HBS1L ANK2 ANK3 PPP1R12B POLR2B CKAP5 CCT2 ANKHD1 ANKRD44 KIDINS220 TNKS ANKS1A | 1.16e-05 | 317 | 164 | 12 | int:HIF1AN |
| Interaction | TNIK interactions | DPYSL2 DPYSL3 ANK2 ANK3 SPTAN1 NBEA DST PRKCG TNKS IKBKB PCDH8 DYNC1H1 EPHA7 | 1.50e-05 | 381 | 164 | 13 | int:TNIK |
| Interaction | PPP1R12B interactions | 1.91e-05 | 68 | 164 | 6 | int:PPP1R12B | |
| Interaction | MYCBP2 interactions | ANK2 DHRS4L2 SPTAN1 CGAS SESN3 TBC1D9 TLR10 SF3B1 DST MMP13 TOP3B DYNC1H1 | 3.53e-05 | 355 | 164 | 12 | int:MYCBP2 |
| Interaction | NAA40 interactions | MRE11 DPYSL2 HAUS6 DPYSL3 ANK2 MAP1A GAPDH ERC1 CKAP5 ACOT7 CCT2 ANKHD1 SF3B1 DST SYNJ1 AHCY PAK2 SNRNP200 TOP1 EPB41L2 ANKS1A | 4.68e-05 | 978 | 164 | 21 | int:NAA40 |
| GeneFamily | Topoisomerases | 4.44e-06 | 6 | 111 | 3 | 1050 | |
| GeneFamily | Ankyrin repeat domain containing | ANK2 ANK3 PPP1R12B ANKHD1 ANKRD44 KIDINS220 ANKRD2 TNKS ANKS1A | 1.83e-05 | 242 | 111 | 9 | 403 |
| GeneFamily | Dyneins, axonemal | 1.44e-04 | 17 | 111 | 3 | 536 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.42e-03 | 134 | 111 | 5 | 861 | |
| GeneFamily | CD molecules|Toll like receptors | 1.63e-03 | 10 | 111 | 2 | 948 | |
| GeneFamily | Kelch like|BTB domain containing | 2.17e-03 | 42 | 111 | 3 | 617 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.32e-03 | 43 | 111 | 3 | 409 | |
| GeneFamily | Annexins|Endogenous ligands | 2.79e-03 | 13 | 111 | 2 | 404 | |
| GeneFamily | ATP binding cassette subfamily C | 2.79e-03 | 13 | 111 | 2 | 807 | |
| GeneFamily | Chaperonins | 3.72e-03 | 15 | 111 | 2 | 587 | |
| GeneFamily | Cadherin related | 4.78e-03 | 17 | 111 | 2 | 24 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | JCAD DDR1 DPYSL3 ANK3 MAP1A PPP1R12B SESN3 SAE1 ANKHD1 ANKRD44 ARL4A BNIP3 KIDINS220 DST GAREM2 TULP4 EFHD1 KIF3C PIGO EPB41L2 EPHA7 PDZRN4 | 1.42e-06 | 1102 | 163 | 22 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | JCAD DDR1 DPYSL3 ANK3 MAP1A PPP1R12B SESN3 SAE1 ANKHD1 ANKRD44 ARL4A BNIP3 KIDINS220 DST GAREM2 TULP4 EFHD1 KIF3C PIGO EPB41L2 EPHA7 PDZRN4 | 1.96e-06 | 1124 | 163 | 22 | MM1070 |
| Coexpression | TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL | JCAD MTIF3 DPYSL2 DPYSL3 FOXN3 FNBP1L LRCH1 BNIP3 PAK2 WDR45B IK EPB41L2 | 9.39e-06 | 405 | 163 | 12 | M41667 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | CDK17 DNAH3 MXRA5 ANK3 NT5E ADAM21 EML6 NBEA PTER LRCH1 PKHD1L1 TBC1D9 ZNF711 ABCB11 | 1.94e-05 | 587 | 163 | 14 | M40869 |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP | 3.52e-05 | 198 | 163 | 8 | M4704 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 3.78e-05 | 200 | 163 | 8 | M9933 | |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_UP | 4.20e-05 | 203 | 163 | 8 | M9695 | |
| Coexpression | LEE_LIVER_CANCER_E2F1_UP | 4.59e-05 | 63 | 163 | 5 | M18438 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 4.80e-05 | 152 | 163 | 7 | M2964 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP | 5.01e-05 | 153 | 163 | 7 | M438 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 8.17e-05 | 14 | 163 | 3 | M2576 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 8.17e-05 | 14 | 163 | 3 | MM961 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.93e-09 | 186 | 164 | 10 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-09 | 195 | 164 | 10 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-09 | 195 | 164 | 10 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-09 | 195 | 164 | 10 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.21e-09 | 196 | 164 | 10 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-08 | 169 | 164 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-08 | 185 | 164 | 9 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-08 | 194 | 164 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.76e-08 | 195 | 164 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.76e-08 | 195 | 164 | 9 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.76e-08 | 195 | 164 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.76e-08 | 195 | 164 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.97e-08 | 196 | 164 | 9 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.97e-08 | 196 | 164 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.97e-08 | 196 | 164 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-08 | 197 | 164 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-08 | 197 | 164 | 9 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.19e-08 | 197 | 164 | 9 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-08 | 197 | 164 | 9 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.19e-08 | 197 | 164 | 9 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.42e-08 | 198 | 164 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 5.66e-08 | 199 | 164 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 5.66e-08 | 199 | 164 | 9 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-08 | 200 | 164 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.91e-08 | 200 | 164 | 9 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-08 | 200 | 164 | 9 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 5.91e-08 | 200 | 164 | 9 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 5.91e-08 | 200 | 164 | 9 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.26e-07 | 184 | 164 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.44e-07 | 185 | 164 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 5.01e-07 | 188 | 164 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-07 | 189 | 164 | 8 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.43e-07 | 190 | 164 | 8 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.43e-07 | 190 | 164 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.43e-07 | 190 | 164 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.11e-07 | 193 | 164 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.11e-07 | 193 | 164 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.11e-07 | 193 | 164 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.11e-07 | 193 | 164 | 8 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.36e-07 | 194 | 164 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-07 | 195 | 164 | 8 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.61e-07 | 195 | 164 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.87e-07 | 196 | 164 | 8 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.14e-07 | 197 | 164 | 8 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.14e-07 | 197 | 164 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.14e-07 | 197 | 164 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.70e-07 | 199 | 164 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 7.70e-07 | 199 | 164 | 8 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 7.70e-07 | 199 | 164 | 8 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 7.70e-07 | 199 | 164 | 8 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.00e-07 | 200 | 164 | 8 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 8.00e-07 | 200 | 164 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 8.00e-07 | 200 | 164 | 8 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 8.00e-07 | 200 | 164 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.00e-07 | 200 | 164 | 8 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.00e-07 | 200 | 164 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 1.25e-06 | 147 | 164 | 7 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 154 | 164 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-06 | 154 | 164 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-06 | 173 | 164 | 7 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-06 | 173 | 164 | 7 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.28e-06 | 177 | 164 | 7 | e68ad19963a3d8917dfdb81127a41c4fcbe61dd5 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.96e-06 | 181 | 164 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-06 | 182 | 164 | 7 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.33e-06 | 183 | 164 | 7 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 185 | 164 | 7 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 185 | 164 | 7 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.73e-06 | 185 | 164 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 185 | 164 | 7 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.73e-06 | 185 | 164 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 6.15e-06 | 187 | 164 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.15e-06 | 187 | 164 | 7 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.36e-06 | 188 | 164 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.36e-06 | 188 | 164 | 7 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 6.36e-06 | 188 | 164 | 7 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.59e-06 | 189 | 164 | 7 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 6.59e-06 | 189 | 164 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 190 | 164 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.82e-06 | 190 | 164 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 190 | 164 | 7 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 6.82e-06 | 190 | 164 | 7 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 190 | 164 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.82e-06 | 190 | 164 | 7 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.82e-06 | 190 | 164 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.06e-06 | 191 | 164 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-06 | 191 | 164 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.06e-06 | 191 | 164 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.06e-06 | 191 | 164 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 7.06e-06 | 191 | 164 | 7 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.06e-06 | 191 | 164 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.30e-06 | 192 | 164 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.30e-06 | 192 | 164 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.30e-06 | 192 | 164 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.55e-06 | 193 | 164 | 7 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| Drug | 9-HME | 1.78e-07 | 8 | 164 | 4 | CID003034753 | |
| Drug | NSC 314622 | 3.63e-06 | 5 | 164 | 3 | CID000329826 | |
| Drug | 3aH-benzimidazole | 3.63e-06 | 5 | 164 | 3 | CID009548683 | |
| Drug | 4-demethoxy-11-deoxy-4'-epi-daunorubicin | 3.63e-06 | 5 | 164 | 3 | CID000158476 | |
| Drug | 4-demethyl-6-O-methyldoxorubicin | 3.63e-06 | 5 | 164 | 3 | CID000126902 | |
| Drug | 2-bromo-dATP | 3.63e-06 | 5 | 164 | 3 | CID000129443 | |
| Drug | NSC622082 | 3.63e-06 | 5 | 164 | 3 | CID000494392 | |
| Drug | eupolauridine | 3.63e-06 | 5 | 164 | 3 | CID000072486 | |
| Drug | intoplicine | 7.22e-06 | 6 | 164 | 3 | CID000065954 | |
| Drug | UCE6 | 7.22e-06 | 6 | 164 | 3 | CID000127735 | |
| Drug | ethoxidine | 7.22e-06 | 6 | 164 | 3 | CID000476777 | |
| Drug | BE-10988 | 7.22e-06 | 6 | 164 | 3 | CID000126200 | |
| Drug | saintopin | 7.22e-06 | 6 | 164 | 3 | CID000131350 | |
| Drug | nitidine | 1.26e-05 | 7 | 164 | 3 | CID000004501 | |
| Drug | AC1L4GCF | 1.26e-05 | 7 | 164 | 3 | CID000156514 | |
| Drug | AC1N9ZZC | 1.29e-05 | 149 | 164 | 8 | CID004369374 | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 2068_DN | |
| Drug | NSC-294410 | 2.00e-05 | 8 | 164 | 3 | CID000457914 | |
| Drug | ardisin | 2.99e-05 | 9 | 164 | 3 | CID000417291 | |
| Drug | IST-622 | 2.99e-05 | 9 | 164 | 3 | CID003081749 | |
| Drug | o-AMSA | 2.99e-05 | 9 | 164 | 3 | CID000107747 | |
| Drug | AC1MZ4R5 | 4.24e-05 | 10 | 164 | 3 | CID003842392 | |
| Drug | diospyrin | 4.24e-05 | 10 | 164 | 3 | CID000308140 | |
| Drug | Edotecarinum | 4.24e-05 | 10 | 164 | 3 | CID000151078 | |
| Drug | AC1L9ENH | 5.16e-05 | 2 | 164 | 2 | CID000443434 | |
| Drug | netropsin | 5.18e-05 | 56 | 164 | 5 | CID000004461 | |
| Drug | 9-aminocamptothecin | 5.36e-05 | 29 | 164 | 4 | CID000072402 | |
| Drug | NSC648766 | 5.79e-05 | 93 | 164 | 6 | CID000003199 | |
| Drug | MDO-CPT | 5.80e-05 | 11 | 164 | 3 | CID000072403 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.06e-05 | 185 | 164 | 8 | 4755_DN | |
| Drug | AC1L6D6Y | 7.70e-05 | 12 | 164 | 3 | CID000265082 | |
| Drug | BD-40 | 7.70e-05 | 12 | 164 | 3 | CID000068853 | |
| Drug | BNP1350 | 7.70e-05 | 12 | 164 | 3 | CID000148202 | |
| Drug | AC1L9QTR | 7.70e-05 | 12 | 164 | 3 | CID000453215 | |
| Drug | ellipticine derivative | 7.70e-05 | 12 | 164 | 3 | CID000434612 | |
| Drug | NC-190 | 7.70e-05 | 12 | 164 | 3 | CID000129234 | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; HL60; HT_HG-U133A | 8.45e-05 | 194 | 164 | 8 | 2741_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 8.45e-05 | 194 | 164 | 8 | 4838_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 2701_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 7048_UP | |
| Drug | 9-NC | 9.02e-05 | 33 | 164 | 4 | CID000123613 | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 4079_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 5770_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 4337_DN | |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 1868_DN | |
| Drug | beta-lapachone | 9.87e-05 | 64 | 164 | 5 | CID000003885 | |
| Drug | 4 pN | 9.95e-05 | 13 | 164 | 3 | CID000078607 | |
| Drug | S 16020-2 | 9.95e-05 | 13 | 164 | 3 | CID000177329 | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A | 1.01e-04 | 199 | 164 | 8 | 1808_UP | |
| Drug | Taxane | 1.02e-04 | 103 | 164 | 6 | CID000108169 | |
| Drug | Indolinone A | 1.14e-04 | 35 | 164 | 4 | ctd:C503753 | |
| Drug | 9-hydroxyellipticine | 1.26e-04 | 14 | 164 | 3 | CID000091643 | |
| Drug | perylenediimide | 1.54e-04 | 3 | 164 | 2 | CID000066475 | |
| Drug | chavibetol | 1.54e-04 | 3 | 164 | 2 | CID000596375 | |
| Drug | 2,2,5,5-tetramethylimidazolidin-4-one | 1.54e-04 | 3 | 164 | 2 | CID009812798 | |
| Drug | v 2182 | 1.54e-04 | 3 | 164 | 2 | CID000078632 | |
| Drug | YS 035 | 1.54e-04 | 3 | 164 | 2 | CID000005714 | |
| Drug | plakinidine A | 1.54e-04 | 3 | 164 | 2 | CID005468016 | |
| Drug | N-ethylethylenediamine | 1.54e-04 | 3 | 164 | 2 | CID000066071 | |
| Drug | protoberberine | 1.57e-04 | 15 | 164 | 3 | CID000114943 | |
| Drug | NMHE | 1.57e-04 | 15 | 164 | 3 | CID000042722 | |
| Drug | Salisorosides Rosavin | 1.62e-04 | 71 | 164 | 5 | CID003340349 | |
| Disease | microfibrillar-associated protein 2 measurement | 2.50e-05 | 11 | 160 | 3 | EFO_0801801 | |
| Disease | level of protocadherin-12 in blood serum | 2.92e-05 | 2 | 160 | 2 | OBA_2042780 | |
| Disease | multiple myeloma | 3.45e-05 | 112 | 160 | 6 | EFO_0001378 | |
| Disease | diacylglycerol kinase beta measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0801525 | |
| Disease | macrophage metalloelastase measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0008220 | |
| Disease | prolyl 4-hydroxylase subunit alpha-2 measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0802918 | |
| Disease | Acute Cerebrovascular Accidents | 2.13e-04 | 54 | 160 | 4 | C0751956 | |
| Disease | Cerebrovascular accident | 3.64e-04 | 62 | 160 | 4 | C0038454 | |
| Disease | Ischemic stroke | 4.08e-04 | 324 | 160 | 8 | HP_0002140 | |
| Disease | dynactin subunit 2 measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0020338 | |
| Disease | complement component 1 q subcomponent-binding protein, mitochondrial measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0020280 | |
| Disease | clusterin measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0007655 | |
| Disease | complement C1r subcomponent measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0008090 | |
| Disease | r-spondin-3 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0021878 | |
| Disease | retinal detachment | 6.03e-04 | 7 | 160 | 2 | EFO_0005773 | |
| Disease | platelet crit | JCAD DNAH3 HBS1L MAP1A HEATR4 LEPR TULP4 CSTF1 PAK2 LRRN2 RP1 UQCRC1 PLOD1 EPB41L2 | 7.12e-04 | 952 | 160 | 14 | EFO_0007985 |
| Disease | alcoholic liver cirrhosis (is_marker_for) | 1.03e-03 | 9 | 160 | 2 | DOID:14018 (is_marker_for) | |
| Disease | tyrosine-protein phosphatase non-receptor type 4 measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0802172 | |
| Disease | cortical surface area measurement | DPYSL2 DPYSL3 PDE3A ANK3 FAT3 PPP1R12B RASGEF1A FNBP1L CLSTN1 LRCH1 ELAC2 SF3B1 TNKS EPHA7 DNAH11 ANKS1A PDZRN4 | 1.05e-03 | 1345 | 160 | 17 | EFO_0010736 |
| Disease | adseverin measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0801358 | |
| Disease | f-box/LRR-repeat protein 4 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0802538 | |
| Disease | pulse pressure measurement | JCAD HAUS6 PDE3A MXRA5 ANK2 FAT3 CKAP5 RNF213 ABCC9 NBEA GOSR2 LRCH1 THBS2 ABCB11 IK CFAP69 RNF207 | 1.52e-03 | 1392 | 160 | 17 | EFO_0005763 |
| Disease | Atrial Fibrillation | 1.84e-03 | 160 | 160 | 5 | C0004238 | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 1.86e-03 | 12 | 160 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 2.26e-03 | 48 | 160 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | multiple myeloma, monoclonal gammopathy | 2.55e-03 | 14 | 160 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.55e-03 | 14 | 160 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | vital capacity | PDE3A MYH7B ERC1 POLR2B ZBTB43 ODAD2 AP3B1 LEPR THBS2 DST TULP4 MYO18B VWA5B1 EPB41L2 ANKS1A | 3.05e-03 | 1236 | 160 | 15 | EFO_0004312 |
| Disease | asthma, response to diisocyanate | 3.09e-03 | 261 | 160 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | R-warfarin measurement | 3.33e-03 | 265 | 160 | 6 | EFO_0803324 | |
| Disease | peanut allergy measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0007017 | |
| Disease | migraine disorder | 3.44e-03 | 357 | 160 | 7 | MONDO_0005277 | |
| Disease | matrix metalloproteinase 12 measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0010590 | |
| Disease | sinusitis (is_marker_for) | 4.22e-03 | 18 | 160 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | Post-Traumatic Osteoporosis | 4.47e-03 | 61 | 160 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 4.47e-03 | 61 | 160 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 4.47e-03 | 61 | 160 | 3 | C0001787 | |
| Disease | emphysema pattern measurement | 4.70e-03 | 19 | 160 | 2 | EFO_0005850 | |
| Disease | anorectal malformation | 4.70e-03 | 19 | 160 | 2 | MONDO_0019938 | |
| Disease | Osteoporosis | 4.90e-03 | 63 | 160 | 3 | C0029456 | |
| Disease | Colorectal Carcinoma | DNAH3 DPYSL2 ANK2 GAPDH TLR9 ABCB11 SNRNP200 PIGO EPHA7 PDZRN4 | 5.11e-03 | 702 | 160 | 10 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERHGGIVKGDEIMAI | 491 | Q9Y6N9 | |
| VHGGTILKMIEEAGA | 71 | O00154 | |
| VAQIHGIGIVKEDDM | 2396 | Q96N23 | |
| HGDAVILGMSSLEQL | 281 | Q8NHP1 | |
| HGDAVILGMSSLEQL | 281 | O95154 | |
| EHIAIEGIMNLGTLK | 1226 | Q68DQ2 | |
| GGDMVHLKDLNTQAV | 366 | Q32M84 | |
| HLRMNISDIGEVKDG | 596 | Q9UKJ8 | |
| LLLLVASGDADMKGH | 11 | Q08345 | |
| KIMLEDGNLHVTQGA | 451 | Q14195 | |
| NLLHTAMKGGVDDEV | 1081 | A8K2U0 | |
| IGDGLKEGLEKLHDM | 171 | P40617 | |
| ISKEIGGDVQKHAEM | 61 | Q01518 | |
| KGAILNGQVHEMSEE | 496 | Q96DT5 | |
| QGVVIEKGTHEELMA | 1291 | O95342 | |
| LAILGEMQTLEGKVH | 716 | O60706 | |
| MGKEQELLEAARTGH | 1 | Q92625 | |
| GHKAVVQVLLDAGMD | 226 | Q92625 | |
| EGEDLGELDKAMQHI | 591 | O94985 | |
| HTAGLLNMGKEEASL | 101 | Q96HY7 | |
| LIEQHEDALHGALKM | 406 | Q8TAM1 | |
| LGHTNVEELMKLGNH | 521 | P00736 | |
| TAAGMVKGVVDHLLL | 181 | Q8N884 | |
| SGETKDHVLGMLLNF | 2176 | Q5H9R4 | |
| HSGSLMLVTVELKEG | 1051 | O00203 | |
| MVHGKEEGLILFDQI | 5151 | Q9HC84 | |
| LDNGAKAVVLMSHLG | 51 | P07205 | |
| EKGTQAGEIHDLKDM | 551 | Q8IUD2 | |
| DGLEIHDKIMEVNGK | 271 | Q6ZMN7 | |
| IAMKHDEVDILGLDG | 1586 | Q9H0J4 | |
| DGEMLQNIKTGLHAV | 1306 | Q4ADV7 | |
| EMQHFLGLKVTGQLD | 66 | P39900 | |
| AGDHVSLTLVGMDII | 546 | Q9Y450 | |
| QEGHTDMVTLLLDKG | 671 | Q01484 | |
| ELHDAMKGLGTKEGV | 101 | P13928 | |
| EKEQHLLMTLVGEQG | 441 | Q9NZ53 | |
| AMAVKLHGGIDILVS | 101 | Q6PKH6 | |
| VKHLLAMGADVDQEG | 186 | Q9ULH0 | |
| TGQLGDVMKESAHLA | 686 | Q86WA8 | |
| QFGELNLGKEEMGHL | 1226 | P78559 | |
| ISDGKLNEGHTLDMD | 371 | O14920 | |
| AVIMGQKHELETADG | 171 | O95665 | |
| KGIQEEMEALVKDHG | 146 | Q16555 | |
| HQEAFMIGDGTVELK | 3666 | Q03001 | |
| GGEEGMDIITHILAL | 266 | Q9Y5R4 | |
| HLKELGLNNMEELVS | 286 | O75325 | |
| MGDILAHESELLGLV | 1 | Q7Z3E5 | |
| KRHLEVSNGMDELAG | 956 | Q9P266 | |
| DIGGLTMESELKRIH | 2791 | Q2LD37 | |
| ENVKGLHLNLGDTIM | 391 | Q8IY21 | |
| IGETLHEMLSKLLGT | 1436 | Q5CZC0 | |
| HDIQKGDESNIAIGM | 5366 | Q5CZC0 | |
| EEFLVVIQAKDMGGH | 221 | Q86UP0 | |
| EKSVHEGALKQDMGE | 826 | O43491 | |
| AAGHEQILTMDVKLG | 26 | O14782 | |
| GQHFEDSKELRLIGM | 406 | O95382 | |
| VIHLFDEKGNDLGNM | 86 | Q9H2K0 | |
| TEQQKIMQHLEGEGL | 91 | Q9BT17 | |
| KMEGDLNDLELQLGH | 1666 | A7E2Y1 | |
| LLAMAHVDLTGDGLQ | 366 | Q9Y664 | |
| LHDGIADIMISFGIK | 156 | P45452 | |
| IGTLAEDLHMKVSGD | 46 | O95206 | |
| DIAVMGEAHGLITDL | 346 | Q14432 | |
| EILELNGESMAGLTH | 266 | Q14005 | |
| AILEEMHLLEGSVGV | 556 | Q96J66 | |
| VSLHEDLGAALMDGV | 596 | Q9Y2L9 | |
| LGLHMEITDDGNLKI | 241 | P48357 | |
| GMDDLILDGHNILDG | 136 | O14653 | |
| QTLLQDGLKDMLDHG | 16 | Q2TBA0 | |
| VMLDAEGHIKITDFG | 486 | P05129 | |
| GHVEMVNLLLAKGAN | 151 | Q8N8A2 | |
| IVHENLKMGSDGESD | 96 | Q00537 | |
| KTIGDLLQVLQEMGH | 81 | Q9Y616 | |
| KMEGEDGIEALKLIH | 401 | Q2M2Z5 | |
| EDVMSLGITLVGHQK | 961 | Q15375 | |
| GSALEKEVESMGAHL | 106 | P31930 | |
| HILDMIEQGSAGKVT | 726 | Q86Y13 | |
| DGIMHKIDIISGTLG | 376 | P22557 | |
| DLGAHHSLLVGQLME | 1446 | Q86WI3 | |
| DGALDEVVLKFEMGH | 211 | Q02809 | |
| TDVLMNEILHGADGT | 146 | Q96BW5 | |
| HRDIKSDNVLLGMEG | 366 | Q13177 | |
| EGHMEILEKLLDNGA | 191 | Q9GZV1 | |
| VMVDHLESEKEGVIG | 1226 | Q14008 | |
| VEQLLGMVEGLVLEH | 201 | Q8WWP7 | |
| VEEEDQHMKLSLGGS | 36 | Q9P2N7 | |
| GGLKEMEQEEVLIHG | 81 | Q53GT1 | |
| GMLTHLDDLQLIQKE | 166 | Q5W0U4 | |
| ELHDAMKGLGTKEGV | 101 | Q5VT79 | |
| GDMEKILLDAQHESG | 41 | Q12983 | |
| DGVKVVLLMTDGIDH | 151 | Q2UY09 | |
| GHNEGTLAMKEGEVL | 551 | Q5T0N5 | |
| KLHGLMEHLEQNLGE | 3431 | Q8TD57 | |
| EEMKEAAGSLLHLAG | 451 | O00409 | |
| KIVDGLGGEHQEMTT | 4251 | Q8TDW7 | |
| QALGQMSLGKEVHDI | 686 | Q86WZ0 | |
| ALGMEESKQLQIHLD | 201 | Q5VWK5 | |
| VFLGHTAIDEMLKLG | 301 | Q9NZP8 | |
| FLKQLLGHMEDLEGD | 211 | Q9NX46 | |
| LGHMEDLEGDAQSVL | 216 | Q9NX46 | |
| AAQEGHVDMVSLLLG | 671 | Q12955 | |
| HKAAAGELQEDSGLM | 156 | Q9BUP0 | |
| GAQKEGLMLDSHEEL | 3036 | Q14204 | |
| GGSEEEFMKILDHLE | 726 | Q7Z4H7 | |
| AASNILIDGHMEGEI | 1676 | Q6ZMW3 | |
| HLGSEAGQMKEIHLE | 1481 | Q8NDH2 | |
| LHLIKLGMENDDTAV | 51 | Q05048 | |
| GTEGVDIVLHVMKTD | 556 | A5D8W1 | |
| ELGMDQHVEKIGEIS | 1341 | Q9P225 | |
| TENKETVISGMGELH | 486 | Q96RP9 | |
| NMILDDGGDLTNLIH | 126 | P23526 | |
| IMKGLLSELLHNCDG | 291 | P40938 | |
| MIHGTLQEADSLDKL | 1896 | P56715 | |
| AGLELDVMGQLHIQD | 56 | Q6P0A1 | |
| HAGDELTLMGQAEIL | 146 | Q75VX8 | |
| GDESQARVLHMVGDK | 181 | Q9NP81 | |
| AEIMGDVLHKSLQLD | 461 | Q6ZRF8 | |
| EEAGNMSHLEILGLS | 136 | Q9BXR5 | |
| MSHLEILGLSGAKIQ | 141 | Q9BXR5 | |
| EVHQGLKDMGLTTLS | 291 | Q5H9J9 | |
| KVELGVIGDSVHMEG | 1286 | O15061 | |
| QIIVNLLGSKEGEHM | 296 | O43426 | |
| LETQLDAHQGLLGMD | 541 | A1L390 | |
| HENGAVKLLLDMVGS | 1001 | Q5T2S8 | |
| AKVIHDNFGIVEGLM | 161 | P04406 | |
| VHLGVSDDLGLLAHM | 1176 | Q8NFP9 | |
| EGHAVGLVKNLALMA | 516 | P30876 | |
| EVMIGEDKLIHFSGV | 351 | P78371 | |
| ILAGVKGLTMLDHEQ | 56 | Q9UBE0 | |
| KQEFLEGGVGHVEML | 46 | Q5MNZ6 | |
| IHLGFMEKDAVRGND | 21 | P49959 | |
| VEMHVKEAGLFGLVN | 96 | Q92781 | |
| HKIDMNLTDLLGELQ | 236 | Q15437 | |
| IALGHSGFEMDKLIA | 216 | P21589 | |
| EGHEEMVALLLAQGA | 481 | Q8IWZ3 | |
| IEMVTGIKEEASHLG | 351 | O43298 | |
| QLAKMLGHSADETIG | 4626 | Q63HN8 | |
| EAELITLMEKHGIGT | 496 | O95985 | |
| LAHVLLHESDGVLGM | 201 | Q9NRJ4 | |
| KMSLEHEGLATADGI | 121 | Q14592 | |
| QDGHLISGSLEALME | 41 | Q8N9B8 | |
| MGKDATLLIHEATLE | 676 | Q9BQ52 | |
| GELHMIELEKGHSGL | 1346 | O75970 | |
| GSLVALKELDMHGIF | 361 | Q9NR96 | |
| MGNLGAADIDHKLEE | 876 | O75533 | |
| NMHVDEFLKTGGIAE | 126 | P58005 | |
| VLKHMSGRVGEELDE | 176 | O60499 | |
| KLDETGNLMISEGHF | 101 | Q13813 | |
| VLADMGHEELKEIGI | 1056 | O95271 | |
| SEEHSLGGQMEDIKL | 1121 | Q6ZT07 | |
| GMGLVNHVFTEDNLK | 66 | Q06203 | |
| LIQESKFLGGDMEHT | 146 | Q13123 | |
| NAKIVGHLDELGMGS | 2706 | Q86WI1 | |
| KINQISLDESGEHMG | 86 | P49754 | |
| ADLIALMEKHGIGTD | 521 | Q13472 | |
| EQVLEHLVGMAGSVD | 671 | Q8IUG5 | |
| IGKHINMDGTINVDD | 521 | O75643 | |
| MLKHGENIIDTLGAE | 531 | Q6PML9 | |
| LENDTLLVVAGDHGM | 266 | Q8TEQ8 | |
| DQGAMLLNVSGHVKE | 661 | P22735 | |
| EHALMEGAKAAGAVI | 251 | Q96KN8 | |
| EELGNMVQELSGLHV | 271 | P35442 | |
| ISLDDVGEKLEHMGN | 206 | Q9Y462 | |
| DNGIDLEATNGMKLH | 301 | Q05996 | |
| GILNKHLQDLMEGLT | 571 | P11387 | |
| HVLIEKGDMTLGEFD | 286 | Q5TIE3 | |
| LMHLDLKGSDIGDNG | 731 | Q86W24 | |
| AGLTKLELLMIHGNE | 76 | Q9NR99 | |
| MAELEHLGGKRAESA | 1 | O60237 |